A surgical orthotopic xenograft approach with immune response for colorectal cancer research.
Ontology highlight
ABSTRACT: The high morbidity and mortality of colorectal cancer (CRC) is a major challenge in clinical practice. Although a series of alternative research models of CRC have been developed, appropriate orthotopic animal models that reproduce the specific clinical response as well as pathophysiological immune features of CRC are still lacking. In the current study, we constructed a CRC orthotopic xenograft model by implanting the tumor tubes at the colorectum of mice and monitored the model development using bioluminescence imaging. This model successfully recapitulates the clinical chemotherapy efficacy, including reduced total flux, tumor weight, and the expression of Ki67 after treatment of the first-line chemotherapy regime of CRC (FOLFOX: oxaliplatin and 5-fluorouracil/calcium folinate). The mod
SUBMITTER: Hou X
PROVIDER: S-EPMC11904094 | biostudies-literature | 2025 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA